Literature DB >> 15707882

Evaluation of nitric oxide and homocysteine levels in primary dysmenorrheal women in Taiwan.

Mao-Feng Sun1, Hui-Chi Huang, Song-Chow Lin, Li-Ping Chang, Chi-Feng Liu.   

Abstract

In this study, we investigated the possible pathophysiological mechanisms in primary dysmenorrhea. The study was undertaken to determine the effect of homocysteine on the nitric oxide (NO) pathway in primary dysmenorrheal women. A total of 94 students from a local nursing college participated. Group 1 consisted of 51 normal subjects with no dysmenorrhea. Group 2 had 43 subjects with dysmenorrheal symptoms. Our results show that serum NO levels in group 2 are higher than those in group 1. However, the serum homocysteine level was lower in group 2. These observations indicate that the NO pathway is involved in the pathophysiological mechanism responsible for the damaging effects of homocysteine on dysmenorrheal women.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15707882     DOI: 10.1016/j.lfs.2004.09.030

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

Review 1.  A review of in vitro and in vivo studies on the efficacy of herbal medicines for primary dysmenorrhea.

Authors:  Kyoung-Sun Park; Kang-In Park; Deok-Sang Hwang; Jin-Moo Lee; Jun-Bock Jang; Chang-Hoon Lee
Journal:  Evid Based Complement Alternat Med       Date:  2014-11-05       Impact factor: 2.629

2.  Network Pharmacology-Based Approach to Investigate the Analgesic Efficacy and Molecular Targets of Xuangui Dropping Pill for Treating Primary Dysmenorrhea.

Authors:  Jihan Huang; Lei Li; Fan Cheung; Ning Wang; Yunfei Li; Zhenyu Fan; Fang Yin; Juan Yang; Rui Gao; Yingchun He; Yibin Feng
Journal:  Evid Based Complement Alternat Med       Date:  2017-10-08       Impact factor: 2.629

3.  Menstrual characteristics, disorders and associated risk factors among female international students in Zhejiang Province, China: a cross-sectional survey.

Authors:  Emmanuel Ansong; Samuel Kofi Arhin; Yaoyao Cai; Xinxin Xu; Xueqing Wu
Journal:  BMC Womens Health       Date:  2019-02-18       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.